Dermatologist Answers Your Skin Care Questions | ‘The Jennifer Hudson Show’

Jennifer Hudson meets Dr. Caroline Robinson, a dermatologist who has treated countless patients, including those with moderate-to-severe plaque psoriasis. Dr. Robinson, who knows that chronic skin conditions can have both an emotional and physical impact, answers common skin care questions. Then, Jennifer announces that the makers of ILUMYA® (tildrakizumab-asmn), a treatment for adults with moderate-to-severe plaque psoriasis, will donate $10,000 to the National Psoriasis Foundation to continue supporting folks on their journey to loving themselves — and their skin.

Discover the stories of real people on ILUMYA® and how they rediscovered self-love and advocated for the best treatment for themselves by visiting https://www.ILUMYA.com/ILUVYA.

#ILUMYApartner

ILUMYA® (tildrakizumab-asmn) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).

SELECT SAFETY INFORMATION

ILUMYA® is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with ILUMYA® and may treat you for TB before you begin treatment with ILUMYA®.

Do not use ILUMYA® if you have had a severe allergic reaction to ILUMYA® or any of its ingredients.

The most common side effects of ILUMYA® include: upper respiratory infections, injection site reactions, and diarrhea. These are not all of the possible side effects of ILUMYA®. Call your doctor for medical advice about side effects.

Please see Important Safety Information and Prescribing Information on ILUMYA.com.